Therapeutic approaches against coronaviruses acute respiratory syndrome.
Pharmacol Res Perspect
; 9(1): e00691, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1384293
ABSTRACT
Coronaviruses represent global health threat. In this century, they have already caused two epidemics and one serious pandemic. Although, at present, there are no approved drugs and therapies for the treatment and prevention of human coronaviruses, several agents, FDA-approved, and preclinical, have shown in vitro and/or in vivo antiviral activity. An in-depth analysis of the current situation leads to the identification of several potential drugs that could have an impact on the fight against coronaviruses infections. In this review, we discuss the virology of human coronaviruses highlighting the main biological targets and summarize the current state-of-the-art of possible therapeutic options to inhibit coronaviruses infections. We mostly focus on FDA-approved and preclinical drugs targeting viral conserved elements.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Infecciones por Coronavirus
/
Coronavirus
/
Dipeptidil Peptidasa 4
/
Síndrome Respiratorio Agudo Grave
/
Enzima Convertidora de Angiotensina 2
/
COVID-19
Límite:
Animales
/
Humanos
Idioma:
Inglés
Revista:
Pharmacol Res Perspect
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
PRP2.691
Similares
MEDLINE
...
LILACS
LIS